HbA1c, Fasting Glucose, and Insulin: Reading Metabolic Risk Together

Fasting glucose measures the concentration of glucose in the blood after an overnight fast. It reflects the balance between hepatic glucose production and insulin-mediated uptake. It is a point-in-time measure — sensitive to recent meals, stress, and sleep — and it is the traditional screening marker for diabetes.

Fasting insulin measures the concentration of insulin in the blood after an overnight fast. It reflects how hard the pancreas is working to maintain glucose control. Elevated fasting insulin — even with normal glucose — is one of the earliest signs of insulin resistance, because the pancreas compensates for resistance by pumping out more insulin to keep glucose in range.

HbA1c measures the percentage of hemoglobin that has glucose attached. Because red blood cells live roughly three months, HbA1c reflects average glucose over that period. It smooths out the day-to-day fluctuations that fasting glucose captures, providing a longer-term view of glycemic control.

Insulin resistance typically develops in a recognizable sequence. First, fasting insulin rises as the pancreas compensates for resistance — glucose stays normal because the extra insulin is doing the work. This is the earliest detectable stage, and it is invisible on a panel that measures only fasting glucose and HbA1c.

Later, glucose begins to creep upward as compensation fails — first into the prediabetes range, then eventually to diabetes. HbA1c follows glucose with a lag, since it reflects a three-month average. By the time HbA1c or fasting glucose is clearly elevated, insulin resistance has often been present for years.

This is why fasting insulin is the most sensitive early marker of the three — and why reading all three together is essential for early detection.

Fasting glucose and fasting insulin can be combined into a single insulin resistance estimate using the HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) equation: HOMA-IR = (fasting insulin × fasting glucose) / 405 (with glucose in mg/dL). A HOMA-IR below 1.0 indicates good insulin sensitivity; above 2.0 suggests significant resistance.

HOMA-IR is not a perfect measure — it is an estimate, not a direct measurement of resistance — but it is a useful way to combine the two fasting values into a single trendable number. Many functional clinicians track HOMA-IR alongside the raw values.

As with other markers, reference ranges describe a population, not an optimal target. Fasting glucose below 100 mg/dL is considered normal, but functional targets often aim for below 90. HbA1c below 5.7% is normal, but functional targets often aim for below 5.3%. Fasting insulin reference ranges vary widely, but functional targets often aim for below 8 μIU/mL.

These tighter targets reflect the evidence that risk begins to climb well before the diagnostic thresholds for prediabetes and diabetes. The goal of preventive tracking is to catch drift toward those thresholds early enough to reverse it with lifestyle change.

Metabolic markers change slowly, and a single value tells you little about direction. A fasting glucose of 95 mg/dL is reassuring if the previous six months were 88, 90, 92, 93, 94, 95 — a stable, low range. The same 95 is concerning if the trend was 82, 84, 87, 90, 93, 95 — a clear upward drift.

This is why a monthly cadence is particularly valuable for metabolic markers. It captures the trajectory that single-point testing cannot, and it lets patients and clinicians see whether lifestyle interventions are reversing the drift — the core goal of preventive metabolic care.

For Metro Detroit patients, metabolic health is a significant regional concern, and early detection of insulin resistance is one of the most impactful preventive interventions available. Monarch Lifestyle Medicine (www.monarchlifestylemed.com) offers lifestyle-medicine-informed metabolic evaluation that can incorporate HOMA-IR and trend data into a personalized risk reduction plan.

The broader Detroit wellness network — including HOK Detroit (www.hokdetroit.com) — supports a coordinated approach to metabolic health, where at-home trend data can inform more targeted and timely clinical conversations.